Regeneron Pharmaceuticals, Inc. (REGN)
782.35
-9.81
(-1.24%)
USD |
NASDAQ |
Feb 19, 16:00
780.00
-2.35
(-0.30%)
After-Hours: 20:00
Regeneron Pharmaceuticals Market Cap : 82.71B for Feb. 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 202.52B |
| Gilead Sciences, Inc. | 187.48B |
| Johnson & Johnson | 594.98B |
| Eli Lilly & Co. | 965.26B |
| Merck & Co., Inc. | 302.45B |
Market Cap Related Metrics
| PE Ratio | 18.82 |
| PS Ratio | 5.925 |
| PEG Ratio | 2.199 |
| Price to Book Value | 2.646 |
| Price to Free Cash Flow | 22.57 |
| Price | 782.35 |
| Earnings Yield | 5.31% |
| Operating PE Ratio | 22.96 |
| Normalized PE Ratio | 19.22 |